TOP TIERMARKET NEWSWIRE
News & sentiment

INHIBRX BIOSCIENCES (INBX) — News & AI sentiment

INHIBRX BIOSCIENCES (INBX) news roundup. 1 story in the past week, 6 over 30 days. Average 30-day sentiment is 50/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 47/100
30d stories
6
avg sentiment 50/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on INBX

5d ago
Jul 17
Jul 17
Jul 16
Jul 16
Jul 16
Jun 15
Jun 15
Inhibrx BLA for ozekibart accepted by FDA
Seeking Alpha73 · bullishgeneral
Jun 15
Jun 15
Jun 15
Jun 3
May 14
May 14
May 8
Open INBX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →